Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study
<p><strong>Background</strong> Ten-valent pneumococcal conjugate vaccine (PCV10), delivered at 6, 10, and 14 weeks of age was introduced in Kenya in January, 2011, accompanied by a catch-up campaign in Kilifi County for children aged younger than 5 years. Coverage with at least two...
主要な著者: | Hammitt, LL, Etyang, AO, Morpeth, SC, Ojal, J, Mutuku, A, Mturi, N, Moisi, JC, Adetifa, IM, Karani, A, Akech, DO, Otiende, M, Bwanaali, T, Wafula, J, Mataza, C, Mumbo, E, Tabu, C, Knoll, MD, Bauni, E, Marsh, K, Williams, TN, Kamau, T, Sharif, SK, Levine, OS, Scott, JAG |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Elsevier
2019
|
類似資料
-
The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria
著者:: Adamu, AL, 等
出版事項: (2023) -
The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria
著者:: Aishatu L. Adamu, 等
出版事項: (2023-05-01) -
Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya
著者:: Ojal, J, 等
出版事項: (2019) -
Effect of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically-confirmed pneumonia and clinically-defined pneumonia in Kenyan children: an interrupted time-series analysis
著者:: Silaba, M, 等
出版事項: (2019) -
Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies
著者:: Dr. Laura L Hammitt, MD, 等
出版事項: (2014-07-01)